BCAX | VRTX | REGN | SGEN | ALNY | ARGX | |
---|---|---|---|---|---|---|
Company Name | Bicara Therapeutics Inc. Common Stock | Vertex Pharmaceuticals Incorporated | Regeneron Pharmaceuticals, Inc. | Seagen Inc. | Alnylam Pharmaceuticals, Inc. | argenx SE |
Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Industry | Biotechnology | Biotechnology | Biotechnology | Biotechnology | Biotechnology | Biotechnology |
Market Cap | $492.46M | $116.96B | $58.10B | $43.15B | $41.50B | $33.28B |
Employees | 0.06K | 6.10K | 15.16K | 3.26K | 2.23K | 1.60K |
CEO | Claire Mazumdar Clemon | Dr. Reshma Kewalramani FASN, M.D. | Leonard S. Schleifer | David R. Epstein | Yvonne L. Greenstreet | Timothy Van Hauwermeiren EMBA, |